Overview of Oki

Quick Facts

Property	Description
Active ingredient	Ketoprofen Lysine Salt
Form	Granules (for oral solution) / Effervescent tablets
Pharmacological class	Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use	Relief of pain, inflammation, and fever
Origin	Synthetic (Propionic acid derivative)

Oki: Definition and Pharmacological Class

Oki is a recognized trade name for a pharmaceutical preparation containing the active substance ketoprofen lysine salt. It is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), belonging to the chemical subgroup of propionic acid derivatives.

This classification designates Oki as a synthetic, single-ingredient agent that possesses anti-inflammatory, analgesic (pain-relieving), and antipyretic (fever-reducing) effects. Ketoprofen and its salts are indicated for symptomatic treatment involving mild to moderate pain. The medicine is suitable for helping to ease general discomfort and related symptoms.

Composition and Forms: Ketoprofen Lysine Salt and Preparation Type

The core active ingredient is the ketoprofen lysine salt, a refined derivative of the standard ketoprofen molecule, engineered to enhance solubility. Oki is formulated for oral administration and is available as rapidly dissolving granules for oral solution or effervescent tablets, a delivery focus distinct from slower-release NSAID preparations.

These systemic preparations, which are taken by mouth, ensure the drug is absorbed through the digestive tract to exert its therapeutic effects across the body. The lysine salt form achieves quicker peak plasma concentrations compared to the free acid form, a characteristic related to the onset of its effects.

General Purpose: What Core Symptoms Does Oki Address?

The general therapeutic purpose of Oki is to provide symptomatic relief by addressing the three primary manifestations of the body's inflammatory response: pain, inflammation, and fever. A typical use scenario includes managing discomfort associated with minor musculoskeletal issues.

As an NSAID, the drug achieves this by interfering with the synthesis of prostaglandins, lipid compounds that act as key chemical messengers that trigger these symptoms. By interrupting this chemical cascade, Oki lessens swelling, reduces discomfort, and assists in controlling an elevated body temperature.

What side effects are possible with Oki?

Safety Profile Summary for Oki (Ketoprofen/Ketoprofen Lysine Salt)

The official safety information for Oki, an NSAID, details risks related to multiple body systems and specifies limitations for its use, as mandated by regulatory authorities like the FDA and EMA.

Key Adverse Reaction Categories

The most serious safety concerns documented in regulatory labels are Cardiovascular Thrombotic Events (including Myocardial Infarction and Stroke) and Serious Gastrointestinal Adverse Events (including bleeding, ulceration, and perforation), which can be fatal. Other serious documented risks include severe cutaneous adverse reactions (SCARs), hepatotoxicity (liver injury), and anaphylaxis.

Frequency-Classified Adverse Reactions

Classification	Examples of Documented Reactions
Common	Nausea, upset stomach, diarrhea, headache, dizziness.
Rare	Severe liver disease, kidney damage, anaphylaxis.

Safety-Related Restrictions and Limitations

Oki is officially contraindicated (must not be used) in patients recovering from Coronary Artery Bypass Graft (CABG) surgery and around or after 20 weeks of pregnancy. Regulatory documents strongly recommend that patients use the lowest effective dose for the shortest duration possible to minimize the risk of serious side effects, as these risks are documented to increase with higher doses and longer duration of use.

Population-Specific Safety Considerations

Special caution is required for elderly patients, who have an increased risk for serious gastrointestinal and renal adverse events. Use in patients with pre-existing conditions such as heart failure, kidney disease, or bleeding problems requires regulatory-specified caution and monitoring.

Connection to the Overall Safety Profile

This structured safety information clearly defines the medicine's risk profile by separating common, mild effects from rare, potentially fatal risks that carry the highest level of regulatory warning. The explicit contraindications and limitations tied to dose and duration establish the boundaries for safe and permissible use of the medicine, strictly adhering to governmental standards.

Overdose and Emergency Response

Overdose and When to Seek Help

Officially documented overdose of Oki (Ketoprofen Lysine Salt) may present with distinct manifestations primarily affecting the gastrointestinal and central nervous systems. Documented signs include vomiting, nausea, epigastric pain, and in some cases, gastrointestinal bleeding. Central nervous system effects such as drowsiness, dizziness, confusion, and agitation are also listed in regulatory information.

Overdose exposure carries a regulatory-documented risk of severe or life-threatening outcomes. These outcomes include coma, seizures (tonic-clonic convulsions), and major organ damage such as acute renal failure and serious gastrointestinal events like ulceration or perforation. Specific population risks are noted for the elderly, who face a higher risk of serious GI events, and children, who are at risk for convulsions.

Regulatory guidance mandates that immediate medical attention be sought, and emergency services or poison control contacted, at the first sign of a suspected overdose. No specific antidote is known for acute NSAID toxicity. Management, therefore, relies strictly on symptomatic and supportive treatment, which may include procedural interventions like activated charcoal or gastric lavage, and required hospital monitoring.

Therapeutic Uses of Oki

What Oki Treats: Main Uses and Benefits

Oki, which contains ketoprofen lysine salt, is commonly used for managing conditions characterized by symptoms related to physical discomfort, inflammation, and fever. The medication plays a role in managing the symptom burden in acute, episodic, and certain chronic conditions involving episodic or fluctuating manifestations. The medication is applied in settings where short-term symptomatic assistance is needed.

The medication is relevant for easing symptoms associated with acute or disruptive episodes, such as those arising from minor musculotendinous trauma (sprains and strains), dental procedures, and the localized discomfort of headache or backache. It is commonly used to help with the pain and stiffness associated with chronic conditions like osteoarthritis and rheumatoid arthritis, and is relevant for managing menstrual cramps (primary dysmenorrhea) and generalized aches and fever from the cold and flu. This function can contribute to improved comfort during periods of heightened symptoms.

Quick Fact: Relief for Acute Discomfort
Primary Focus	Symptoms that interfere with daily functioning, specifically pain, swelling, and fever.
Core Benefit	Provides supportive relief when symptoms intensify, assisting with short-term symptom management.
Key Scenarios	Post-traumatic, post-procedural, and episodic conditions.

Regulatory References

NIH MedlinePlus overview of Ketoprofen

Eligibility and Restrictions for Use

Oki (ketoprofen lysine salt) is an NSAID with specific regulatory criteria defining who is eligible to use the medicine. Eligibility is determined by age, pre-existing health conditions, and physiological state.

Eligibility Scope

Classification	Population or Condition
Populations Allowed	Adults and adolescents (minimum age typically 16 or 18, varying by regional approval).
Populations Contraindicated	Patients with known hypersensitivity to ketoprofen or other NSAIDs (including aspirin-induced asthma) [1.1, 1.2].
	Individuals with severe cardiac insufficiency, active gastrointestinal bleeding, or a history of ulceration/perforation [1.1, 1.4].
	Treatment of peri-operative pain in the setting of CABG surgery [1.4].
Age-Related Rules	Pediatric use (under 18) is generally documented as safety and efficacy not established [2.3].
	Elderly patients require caution and close monitoring due to increased risk of serious gastrointestinal and renal adverse events [1.1, 1.3].
Condition-Specific Caution	Use requires caution in patients with renal or hepatic impairment, uncontrolled hypertension, or a history of inflammatory gastrointestinal disease [1.1, 1.2].
Pregnancy/Lactation	Contraindicated during the third trimester of pregnancy and while breastfeeding [1.1]. Use is generally restricted between 20 and 30 weeks of pregnancy [3.6].

Eligibility Classifications

Regulatory documents use these defined criteria to establish absolute contraindications across several physiological systems (GI, Cardiac, Allergic). Use in specific high-risk groups, such as those with organ impairment, requires the regulatory classification of caution and monitoring, whereas use in the general pediatric population is typically classified as not established.

What should I know about interactions with other medicines?

Ketoprofen Lysine Salt (Oki) exhibits several officially documented interactions, which are classified by regulatory authorities based on the resulting clinical outcome. These interactions primarily fall into the categories of pharmacodynamic risk reinforcement and pharmacokinetic alteration, establishing mandatory constraints for co-administration.

Mandatory Regulatory Prohibitions

Interaction Type	Condition/Substance
Contraindicated Use	Treatment of perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.
Contraindicated Combination	Co-administration with other systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs).

Officially Documented Interaction Statements

Co-administration with Anticoagulants, Antiplatelet Agents, Oral Corticosteroids, and SSRIs is documented to increase the risk of hemorrhage or serious gastrointestinal adverse events due to additive pharmacodynamic effects.
The drug can significantly increase the plasma concentration of Lithium, potentially resulting in toxicity, as stated in regulatory documents. Caution is also advised regarding the potential to increase the plasma concentration of Methotrexate (MTX).
The effectiveness of Diuretics and ACE Inhibitors/ARBs (e.g., Lisinopril, Losartan) may be reduced, and their combination is associated with an increased risk of renal injury.
The official labeling confirms that co-administration with Alcohol (Ethanol) increases the documented risk of serious gastrointestinal bleeding.
Elderly Patients are a population noted to have a higher inherent risk for gastrointestinal events, which heightens the risk profile for interactions involving bleeding-risk agents.

Mechanism of Action

The mechanism of action for Ketoprofen Lysine Salt involves direct interaction with multiple biological targets that modulate chemical pathways. The high solubility of the lysine salt allows the molecule to rapidly access both peripheral and central targets, which results in the rapid achievement of target concentrations.

Non-Selective Enzyme Blockade in the Inflammatory Cascade

This domain covers the drug's primary action: the reversible, non-selective inhibition of the Cyclooxygenase ( COX) enzymes. By blocking COX-1 and COX-2, the drug prevents the conversion of arachidonic acid into prostaglandins, which are key lipid mediators that influence local vascular tone and neural signaling.

Dual Anti-Mediator Modulation and Signaling Interference

The mechanism extends beyond COX inhibition, engaging in dual pathway modulation by also inhibiting the Lipoxygenase ( LOX) pathway and suppressing the activity of the pain mediator Bradykinin. This combined action decreases the production of both PGs and Leukotrienes ( LTs), which are chemical agents that influence cell migration and vascular permeability.

Central and Peripheral Physiological Regulation

The drug’s molecular action translates into systemic physiological changes by targeting processes in both the periphery and the Central Nervous System ( CNS). In the CNS, the mechanism involves resetting the elevated hypothalamic temperature set-point and modulating spinal cord pathways, which results in the reduction of signal transmission.

Dosage and Administration Information

Administration Guidelines for Oki

Oki (ketoprofen lysine salt) is administered exclusively through the oral route as either film-coated tablets or rapidly dissolving granules for oral solution. The medicine is used on an as-needed (PRN) basis for symptomatic relief, following instructions to govern intake patterns.

Standard Dosing and Frequency

Feature	Instruction
Standard Single Dose	25 mg (one sachet or tablet).
Minimum Interval	Four hours between successive doses.
Maximum Daily Dose	Do not exceed 75 mg (three doses) in 24 hours.
Duration Principle	Strictly for short-term use only, applying the lowest effective dose.

Preparation and Population-Specific Rules

Administration details vary by formulation. Granules are typically placed directly onto the tongue and swallowed, and intake may occur with or without water. Intake on a full stomach may be preferred.

Usage limits apply to certain populations. The product is not recommended for use in children or adolescents under the age of 18 years. For older adults, the recommended maximum dose is 25 mg (one dose) per day. If symptoms require the medicine for more than 10 days, consultation with a healthcare professional is necessary.

Recent Clinical Evidence

Research Evidence / Overview of Studies

This section provides an evidence-neutral overview of clinical and non-clinical research that has investigated the drug's properties and potential applications. It does not constitute medical advice or a recommendation for use.

Mechanisms and Efficacy Studies

Initial in vitro and animal studies investigated its use in conditions characterized by specific receptor activity. Research has explored the drug's properties.

Phase I (Tolerability): Early-stage studies investigated the drug’s tolerability and pharmacokinetics in healthy volunteers.
Phase II (Dose-finding): Medium-scale research examined various concentration levels and their impact on early biomarkers, with different results observed across the investigated cohorts.
Phase III (Pivotal Studies): Large-scale, double-blind, placebo-controlled trials investigated the drug’s performance in a specific chronic disease setting. These studies examined the timeline of observed changes in comparison to placebo.

Combination Therapy Research

Research has also evaluated the studied drug when administered alongside a common adjuvant. Studies explored the administration of the drug under specific clinical protocols.

Safety and Patient Groups

Clinical trials have monitored potential adverse events and contraindications.

Tolerability Profile: Research examined the short- and long-term tolerability of the drug.
Specific Populations: Studies included subjects with severe liver impairment to monitor tolerability. Research investigated the drug’s activity in certain autoimmune models.
Off-Label Inquiry: Further research is needed to explore the drug’s use outside of the studied indication.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Oki (FAQ)

Q: How quickly does Oki start to work for pain?

Studies indicate that the formulation of Oki (ketoprofen lysine salt) is designed for rapid absorption and a fast onset of its pain-relieving effects. The lysine salt is noted to achieve its highest concentration in the body very quickly, typically reaching peak concentrations around 15 to 30 minutes after administration, based on pharmacokinetic studies.

Q: What is the expected length of time Oki's effects last?

Pharmacokinetic data from official sources suggest that the active ingredient has a relatively short half-life, meaning it is quickly processed by the body. This pharmacokinetic profile informs the administration schedule, with successive doses typically separated by at least four hours.

Q: Is Oki the same type of medicine as ibuprofen or aspirin?

Yes, Oki is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), placing it in the same drug class as both ibuprofen and aspirin. Official product information confirms that its active ingredient, ketoprofen, is classified as an NSAID and functions as a prostaglandin inhibitor.

Q: What is the difference between Oki and other common painkillers?

Oki's formulation as a lysine salt is its key difference, as this allows for faster absorption and a quicker start to its action compared to the standard ketoprofen molecule. Its mechanism of action is also noted to involve a dual pathway of modulating inflammatory chemicals, which is a distinguishing feature described in official documents.

Q: Is it mandatory to take Oki with food?

Official regulatory documents generally state that Oki can be taken with or without food. However, official guidance mentions that taking the product on a full stomach may be considered to help prevent stomach upset.

Q: Can Oki be taken alongside common cold and flu remedies?

Official interaction warnings state that Oki should not be taken with other systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs), as this increases the risk of serious side effects. Patients are advised to check the ingredients of any co-administered products to avoid unintentional contraindications.

Q: Does Oki affect fertility or reproductive health?

Regulatory-linked documents carry a warning that the active ingredient in Oki is suspected of potentially damaging fertility or an unborn child. Furthermore, its use is specifically restricted during the third trimester of pregnancy.

Q: Why is Oki sometimes used for dental pain?

Oki is an anti-inflammatory drug and its general authorized indication is for symptomatic pain relief, which includes various types of acute pain. Clinical reviews and evidence state that the drug is effective in managing pain, including pain associated with dental procedures and toothaches.

Q: Does Oki contain codeine or narcotics?

No, Oki does not contain codeine or narcotics. Its classification as a Nonsteroidal Anti-inflammatory Drug (NSAID) means its sole active component is ketoprofen lysine salt, which is a non-narcotic pain reliever.

Q: Can Oki be used for period pain (menstrual cramps)?

Yes, official drug labeling for the immediate-release formulation of ketoprofen specifically lists menstrual cramps (dysmenorrhea) as one of the pain conditions for which the medicine is indicated and used to provide symptomatic relief.

Q: Is it common for Oki to be used for headaches or migraines?

While Oki is generally indicated for pain relief, specific clinical trials have investigated the use of oral ketoprofen for acute episodic tension-type headaches. These studies suggest the medicine can provide a benefit, which is consistent with its general pain-relieving effects.

Q: Is Oki available without a prescription in some places?

The regulatory status of Oki varies by country and the strength of the dose. In some regions, lower dosage forms of ketoprofen may be available for sale without a prescription (over-the-counter), but higher doses generally require a healthcare professional's prescription.

Q: Is a metallic taste in the mouth possible after taking Oki?

Yes, regulatory-linked side effect profiles have documented taste perversion (also known as dysgeusia) as a possible adverse reaction. This condition could manifest as a changed or metallic taste in the mouth after taking the medicine.

Q: Is Oki safe for older adults to take?

A specific lower dosage is often recommended for the elderly, and regulatory bodies advise monitoring due to their increased risk for serious adverse events. This caution applies especially to patients over the age of 75.

Q: Can Oki be taken by people with asthma?

Official contraindications state that Oki should not be used by patients with a history of asthma, hives, or other allergic-type reactions to aspirin or other NSAIDs. This is due to a known risk of severe bronchospasm (narrowing of the airways) in sensitive individuals.

Q: Is Oki used for chronic pain or just short-term relief?

Regulatory guidance emphasizes that Oki is strictly intended for short-term use only for the symptomatic relief of acute pain. It is not generally indicated or recommended for the long-term management of chronic pain conditions.

Q: How does Oki's liquid formulation compare to tablets?

The liquid formulation (granules for oral solution) is associated with the enhanced solubility of the lysine salt. This design feature facilitates rapid dissolution and absorption in the digestive tract, contributing to its fast onset of action compared to solid tablets.

Q: Is there a risk of dependency or addiction with Oki?

Oki is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), not an opioid or narcotic. Therefore, the concerns regarding dependency and addiction associated with narcotic painkillers do not apply to this type of medicine.

Q: What is the common age limit for children using Oki?

Official administration guidelines state that Oki is not recommended for use in children or adolescents under the age of 18 years. This restriction is in place because the safety and effectiveness of the medicine have not been conclusively established in this pediatric age group.

Q: Is Oki known to cause drowsiness?

Yes, official side effect lists include drowsiness (somnolence) and dizziness as possible adverse reactions. These effects are officially classified as common in the drug's safety profile.

Q: Does Oki have a significant risk of allergic reaction?

Oki is contraindicated for use in patients with a known history of hypersensitivity to NSAIDs (including aspirin). Furthermore, regulatory warnings note the rare but serious risk of anaphylaxis, which is a severe allergic reaction.

Q: Are there specific official guidelines on the maximum duration Oki can be taken?

Official administration protocol emphasizes that Oki should be taken for the shortest duration possible. Regulatory guidelines specify that if a person's symptoms continue to require the medicine for more than 10 days, consultation with a healthcare professional is necessary.

Q: Why might a doctor prescribe Oki instead of a different NSAID?

A prescriber may consider Oki due to its specific chemical properties, such as its faster absorption and quicker onset of action that is achieved by the lysine salt formulation. This makes it a useful option for symptomatic relief of acute pain.

Q: How does Oki influence blood clotting?

As an NSAID, Oki works by non-selectively inhibiting the COX enzyme, which prevents the synthesis of certain prostaglandins. This action is known to affect platelet aggregation, the process essential for blood clotting. This effect is why the product is associated with an increased risk of bleeding.

Q: Can Oki worsen symptoms of heart conditions?

Official safety warnings state that Oki is associated with an increased risk of serious cardiovascular thrombotic events (like heart attack or stroke). It is officially contraindicated (must not be used) in patients with severe heart failure.

How should Oki be stored and disposed of?

How to Store and Dispose of Oki (Ketoprofen Lysinate)

Oki must be stored under specific conditions to maintain its quality and safety. The medicine should be kept in its original packaging, which must be tightly closed to protect from light and moisture. Storage should be at room temperature, and the product must be kept out of the sight and reach of children.

Official Disposal Guidance

Do not use Oki after the expiry date (EXP) printed on the carton. The medicine must not be thrown away via wastewater or household waste. Official guidance requires that the user ask a pharmacist how to dispose of any medicines that are no longer needed to ensure environmentally safe procedures are followed.

Oki

Oki

Selected form

Medically reviewed